“Comparatively Analysis of Adverse Events amongst 0.5% Hyperbaric Bupivacaine and 0.75%  isobaric Bupivacaine at Same Dose 12mg  in Patients Undergoing Caesarean Sections”, AMAR, vol. 4, no. 2, pp. 581–588, Feb. 2026, Accessed: Oct. 17, 2026. [Online]. Available: https://www.amresearchjournal.com/index.php/Journal/article/view/2314